Revolution Medicines Inc
NASDAQ:RVMD 4:00:00 PM EDT
| Market Cap (Intraday) | 5.74B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $35.25 |
| 50-Day MA | $31.70 |
| 200-Day MA | $28.24 |
Revolution Medicines Inc Stock, NASDAQ:RVMD
700 Saginaw Drive, Redwood City, California 94063
United States of America
Phone: +1.650.481.6801
Number of Employees: 378
Description
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.